MSH2 and prostate cancer: Because most patients with Muir–Torre syndrome are MSH2-deficient and prostate cancers with MSH2 deficiency tend to have higher Gleason scores, early detection and treatment are important for prostate cancer patients with Muir–Torre syndrome.